Doxorubucin (DOX) and the cardioprotective agent, ICRF 187, have additive cytotoxicities for the murine sarcoma S180 cell line

S. Wadler, M. Green, D. Polsky, F. Muggia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	No. 1350
Journal	Proceedings of the American Association for Cancer Research
Volume	VOL. 26
State	Published - 1 Jan 1985
Externally published	Yes

ASJC Scopus subject areas

@article{caad5cf19479473ebd48786156cac8a0,

title = "Doxorubucin (DOX) and the cardioprotective agent, ICRF 187, have additive cytotoxicities for the murine sarcoma S180 cell line",

author = "S. Wadler and M. Green and D. Polsky and F. Muggia",

year = "1985",

month = jan,

day = "1",

language = "English",

volume = "VOL. 26",

pages = "No. 1350",

journal = "Proceedings of the American Association for Cancer Research",

}

TY - JOUR

T1 - Doxorubucin (DOX) and the cardioprotective agent, ICRF 187, have additive cytotoxicities for the murine sarcoma S180 cell line

AU - Wadler, S.

AU - Green, M.

AU - Polsky, D.

AU - Muggia, F.

PY - 1985/1/1

Y1 - 1985/1/1

UR - http://www.scopus.com/inward/record.url?scp=0021951221&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0021951221

VL - VOL. 26

SP - No. 1350

JO - Proceedings of the American Association for Cancer Research

JF - Proceedings of the American Association for Cancer Research

ER -